EQL Pharma AB publ announced earnings results for the second quarter ended September 30, 2020. For the second quarter, the company announced sales was SEK 24.221 million compared to SEK 17.868 million a year ago. Operating income was SEK 3.399 million compared to SEK 1.153 million a year ago. Net income was SEK 3.239 million compared to SEK 1.062 million a year ago. For the half year, sales was SEK 123.726 million compared to SEK 32.327 million a year ago. Operating income was SEK 14.973 million compared to SEK 1.234 million a year ago. Net income was SEK 14.448 million compared to SEK 1.076 million a year ago.